These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 24689695)

  • 1. A nurse-guided, basal-prandial insulin treatment protocol for achieving glycaemic control of hospitalized, non-critically ill diabetes patients, is non-inferior to physician-guided therapy: A pivotal, nurse-empowerment study.
    Segal G; Karniel E; Mahagna A; Kaa'dan F; Levi Z; Balik C
    Int J Nurs Pract; 2015 Dec; 21(6):790-6. PubMed ID: 24689695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.
    Ligthelm RJ; Mouritzen U; Lynggaard H; Landin-Olsson M; Fox C; le Devehat C; Romero E; Liebl A
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):511-9. PubMed ID: 17115349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and feasibility of basal-bolus insulin regimens and a discharge-strategy in hospitalised patients with type 2 diabetes--the HOSMIDIA study.
    Pérez A; Reales P; Barahona MJ; Romero MG; Miñambres I;
    Int J Clin Pract; 2014 Oct; 68(10):1264-71. PubMed ID: 25269951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycaemic control in type 2 diabetes mellitus patients undergoing major surgery: comparison of three subcutaneous insulin regimens.
    Mathur SK; Bansal A; Khan ZY
    J Indian Med Assoc; 2009 Nov; 107(11):759-61. PubMed ID: 20469779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: results of the OSIRIS study.
    Raccah D; Haak TJ; Huet D; Monnier L; Robertson D; Labard P; Soler J; Penfornis A
    Diabetes Metab; 2012 Dec; 38(6):507-14. PubMed ID: 23116646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.
    Bowering K; Reed VA; Felicio JS; Landry J; Ji L; Oliveira J
    Diabet Med; 2012 Sep; 29(9):e263-72. PubMed ID: 22672081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus.
    Pfützner A; Hermanns N; Funke K; Forst T; Behnke T; Bitton G; Nagar R; Raz I; Haak T
    Curr Med Res Opin; 2014 May; 30(5):753-60. PubMed ID: 24392996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).
    Umpierrez GE; Smiley D; Zisman A; Prieto LM; Palacio A; Ceron M; Puig A; Mejia R
    Diabetes Care; 2007 Sep; 30(9):2181-6. PubMed ID: 17513708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality improvement project for improving inpatient glycaemic control in non-critically ill patients admitted on medical floor with type 2 diabetes mellitus.
    Khan AA; Shahzad A; Rose S; Al Mohanadi DHSH; Zahid M
    BMJ Open Qual; 2020 Aug; 9(3):. PubMed ID: 32792342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective switch from premixed to basal-prandial insulin to achieve glycemic goals in type 2 diabetes.
    Lavernia F
    Postgrad Med; 2010 May; 122(3):28-32. PubMed ID: 20463411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study.
    Schroeder JE; Liebergall M; Raz I; Egleston R; Ben Sussan G; Peyser A; Eldor R
    Diabetes Metab Res Rev; 2012 Jan; 28(1):71-5. PubMed ID: 21584922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice nurses can improve insulin uptake in type 2 diabetes.
    Lockyer M
    Practitioner; 2017 Apr; 261(1803):5. PubMed ID: 29020727
    [No Abstract]   [Full Text] [Related]  

  • 14. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
    Meneghini L; Koenen C; Weng W; Selam JL
    Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
    Clements MR; Tits J; Kinsley BT; Råstam J; Friberg HH; Ligthelm RJ
    Diabetes Obes Metab; 2008 Mar; 10(3):229-37. PubMed ID: 18269638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of insulin glargine in suboptimally controlled patients with type 2 diabetes: sub-analysis of the AT.LANTUS trial comparing treatment outcomes in subjects from primary and secondary care in the UK.
    Davies M; Evans R; Storms F; Gomis R; Khunti K
    Diabetes Obes Metab; 2007 Sep; 9(5):706-13. PubMed ID: 17697063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness, safety and feasibility of an evidence-based insulin infusion protocol targeting moderate glycaemic control in intensive cardiac care units.
    Avanzini F; Marelli G; Saltafossi D; Longhi C; Carbone S; Carlino L; Planca E; Vilei V; Roncaglioni MC; Riva E;
    Eur Heart J Acute Cardiovasc Care; 2016 Apr; 5(2):117-24. PubMed ID: 25735300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes.
    Mu PW; Chen YM; Lu HY; Wen XQ; Zhang YH; Xie RY; Shu J; Wang MM; Zeng LY
    Diabetes Metab Res Rev; 2012 Mar; 28(3):236-40. PubMed ID: 21898754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLP-1 RAs as compared to prandial insulin after failure of basal insulin in type 2 diabetes: lessons from the 4B and Get-Goal DUO 2 trials.
    Porcellati F; Lucidi P; Bolli GB; Fanelli CG
    Diabetes Metab; 2015 Dec; 41(6 Suppl 1):6S16-6S20. PubMed ID: 26774015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.